Trium Capital »

Cerevel Therapeutics Hldng I shares owned by Trium Capital

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Trium Capital from 13F filings

Historical chart of Trium Capital investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Trium Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Trium Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 318k 40.89

More positions owned by Trium Capital

Spdr S&p 500 Etf Trust Tr Unit Put Option (SPY)
Kraneshares Csi China Intern Csi Chi Internet (KWEB)
Ishares China Large-cap Etf China Lg-cap Etf (FXI)
Olink Holding Ab - Sponsored Ads (OLK)
Us Silica Hldgs (SLCA)
Vaneck Vietnam Etf Vaneck Vietnam (VNM)
Cerevel Therapeutics Hldng I (CERE)
Hollysys Automation Technolo SHS (HOLI)
National Western Life Grou-a Cl A (NWLI)
Encore Wire Corporation (WIRE)
Otis Worldwide Corp (OTIS)
Abbott Laboratories (ABT)
UnitedHealth (UNH)
Moody's Corporation (MCO)
Everbridge, Inc. Cmn (EVBG)

View all positions for Trium Capital

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Perceptive Advisors
venBio Select Advisor
Vanguard Group
BlackRock
Fil
State Street Corporation
Millennium Management
Alpine Associates Management
Paradigm Biocapital Advisors
Pentwater Capital Management
Soros Fund Management
LMR Partners
Marshall Wace
FMR

View all funds holding Cerevel Therapeutics Hldng I